ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2013

TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.

Xiaohong Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.